Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
JOHNSON & JOHNSON
Bear Case (25th pct.)
-40.1% vs price
Base Case (Median)
-27.5% vs price
Bull Case (75th pct.)
6.1% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $374.84 | 40.2% | High (40%) |
| PE Comparable | $193.67 | -27.5% | Medium (25%) |
| Growth Trajectory DCF | $275.57 | 3.1% | Medium (20%) |
| Graham Number | $81.10 | -69.7% | Medium (40%) |
| EV/EBITDA | $135.34 | -49.4% | Medium (20%) |
| EV/FCF | $184.80 | -30.9% | Medium (20%) |
| Earnings Power Value | $291.61 | 9.1% | Medium (50%) |
Based on 7 out of 7 methods, JNJ appears fairly valued at the current price of $267.28. The base case fair value of $193.67 implies 27.5% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.